Company / Operating Margin
Vanda Pharmaceuticals Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-7.2%
FY2025
5-year range
-7.2% / 15.7%
FY2021-FY2025
Trend
-390.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -391% YoY in FY2025, a notable deviation from the 9-year average annual change of -37%.
Based on SEC 10-K filings.
-7.2% in FY2025 with a 5-year CAGR of -18.5%.
Declined from 15.7% to -7.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -18.2pp
- 5-Year Change
- -18.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 390.8% year-over-year.
- Peak operating margin was recorded in FY2016.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7.2% | -390.8% |
| FY2024 | 2.5% | -84.1% |
| FY2023 | 15.7% | +42.9% |
| FY2022 | 11.0% | +9.4% |
| FY2021 | 10.0% | -10.8% |
| FY2020 | 11.3% | +210.0% |
| FY2019 | -10.2% | +19.5% |
| FY2018 | -12.7% | +65.2% |
| FY2017 | -36.6% | -191.4% |
| FY2016 | 40.0% | +163.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026